← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 1, 2008Last known activity
Mar 21, 2016
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 2 trials)
Phase 2 (3 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT03360266Study directorN/AMar 21, 2016
- NCT03360266Reponsible party - principal investigatorN/AMar 21, 2016
- NCT03360266Lead sponsorN/AMar 21, 2016
- NCT00680940Overall official - principal investigatorPhase 2Jun 1, 2008
Details
- Last known activity
- Mar 21, 2016